Additionally, PRMT6 methylates CRAF at R100, preventing its interaction with RAS and facilitating nuclear translocation of PKM2, which contributes to glycolytic reprogramming in HCC [423]. This evidence concerns the gene PRMT6 and hepatocellular carcinoma.